-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation
- Share
- Tweet
- Share on Facebook
- Share
Poster titled: Glioblastoma Diagnosis and Monitoring through Nucleosome Epigenetic
Modifications Tracking
Pei-Hsing Chen, Tai-Horng Young, T.-P. Lu, D. Pamart, A. Kotronoulas, M. Herzog, J. Micallef, Hsao-Hsun Hsu, Jin-Shing Chen
Presented at ESMO 2025
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields